Search For "zydus cadila"
Zydus Cadila's net profit up 41 pc in Q3 to Rs 527 crore
Updated : 5 years, 1 month ago IST
Ahmedabad (Gujarat) [India], February 5 (ANI): Pharmaceutical major Zydus Cadila said on Friday its profit after tax was up by 41 per cent to Rs 527 crore in Q3 FY21 as compared to the corresponding quarter of previous year.
Read More
Zydus Cadila gets DCGI nod for Phase-3 clinical trials for Covid-19 vaccin
Updated : 5 years, 2 months ago IST
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
Read More
PM Modi's visit has encouraged us in doing more, doing fast: Zydus Cadila
Updated : 5 years, 3 months ago IST
Ahmedabad (Gujarat) [India], November 28 (ANI): Zydus Cadila chairperson Pankaj K Patel said on Saturday that Prime Minister Narendra Modi's visit to Zydus Biotech Park here had encouraged the staff to "doing more and doing fast" in relation to the COVID-19 vaccine and his knowledge, wisd
Read More
PM Modi visits Zydus Biotech Park in Ahmedabad
Updated : 5 years, 3 months ago IST
Ahmedabad (Gujarat) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday arrived in Ahmedabad and proceeded to Zydus Biotech Park of the pharma major Zydus Cadila to review the vaccine development.
Read More
Three COVID-19 vaccines at clinical trial stage in India: ICMR DG
Updated : 5 years, 5 months ago IST
New Delhi [India], September 15 (ANI): Three COVID-19 vaccines are at a clinical trial stage in the country and two indigenous vaccine candidates have completed phase one trial, Indian Council of Medical Research (ICMR) DG Dr Balram Bhargava said on Tuesday.
Read More
Two Indian vaccine candidates against COVID-19 in phase two trials: VK Pau
Updated : 5 years, 6 months ago IST
New Delhi [India], Aug 29 (ANI): Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR and Zydus Cadila's candidate based on viral DNA are two Indian COVID-19 vaccines in second phase trial, Niti Aayog member Dr Vinod K Paul said on Saturday.
Read More
At Rs 2,800, Zydus launches Remdac for treatment of COVID-19 in India
Updated : 5 years, 7 months ago IST
Ahmedabad (Gujarat) [India], Aug 13 (ANI): Pharmaceutical major Zydus Cadila said on Thursday it has launched Remdesivir under the brand name Remdac for treatment of COVID-19 in the Indian market.
Read More
Pharma giant Zydus Cadila initiates clinical study on 1,048 volunteers for
Updated : 5 years, 8 months ago IST
New Delhi [India], July 15 (ANI): Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from D
Read More
Zydus gets Mexican regulator nod for Desidustat in test management of COVI
Updated : 5 years, 8 months ago IST
Ahmedabad (Gujarat) [India], July 6 (ANI): Pharmaceutical major Zydus Cadila said on Monday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its one of its lead research candidate Desidustat to be tested in the management of COVID-1
Read More
Zydus' vaccine for COVID-19 completes pre-clinical development, to initiat
Updated : 5 years, 8 months ago IST
Ahmedabad (Gujarat) [India], July 3 (ANI): Healthcare major Zydus Cadila said on Friday its plasmid DNA vaccine candidate for COVID-19 (ZyCoV-D) developed indigenously at its vaccine technology centre here has successfully completed the pre-clinical phase.
Read More
DCGI permits human clinical trials for COVID-19 vaccine of Zydus Cadila
Updated : 5 years, 8 months ago IST
New Delhi [India], July 3 (ANI): The Drug Controller General of India (DCGI) on Thursday granted permission to pharma giant Zydus Cadila to conduct phase I and phase II human clinical trials for COVID -19 vaccine, a top government official told ANI.
Read More
Zydus signs licensing agreement with Gilead to manufacture and market Remd
Updated : 5 years, 9 months ago IST
Ahmedabad (Gujarat) [India], June 13 (ANI): Healthcare major Zydus Cadila has signed a non-exclusive licensing agreement with Gilead Sciences Inc for the manufacturing and distribution of Remdesivir, the investigational drug which has been issued an emergency use authorisation by the US Food
Read More